Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 022047
Company: ASTRAZENECA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SEROQUEL XR QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB Yes No
SEROQUEL XR QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB Yes Yes
SEROQUEL XR QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB Yes No
SEROQUEL XR QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB Yes No
SEROQUEL XR QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/17/2007 ORIG-1 Approval Type 3 - New Dosage Form UNKNOWN Letter (PDF)
Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022047Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022047s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/23/2017 SUPPL-39 Labeling-Package Insert, Labeling-Medication Guide Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022047s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020639Orig1s065,022047Orig1s039ltr.pdf
06/17/2016 SUPPL-38 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022047s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020639Orig1s064,022047Orig1s038ltr.pdf
01/26/2015 SUPPL-36 Manufacturing (CMC) Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022047s036lbl.pdf
10/29/2013 SUPPL-34 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020639Orig1s061,022047Orig1s034ltr.pdf
04/30/2013 SUPPL-31 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020639Orig1s053,s057,s058,s059;022047s026,029,s030,s031ltr.pdf
04/30/2013 SUPPL-30 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020639Orig1s053,s057,s058,s059;022047s026,029,s030,s031ltr.pdf
04/30/2013 SUPPL-29 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020639Orig1s053,s057,s058,s059;022047s026,029,s030,s031ltr.pdf
11/09/2011 SUPPL-28 REMS-Modified Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022047s028ltr.pdf
07/08/2011 SUPPL-27 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s023s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022047s023,s027ltr.pdf
04/30/2013 SUPPL-26 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020639Orig1s053,s057,s058,s059;022047s026,029,s030,s031ltr.pdf
12/01/2010 SUPPL-25 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022047s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022047s025ltr.pdf
05/17/2011 SUPPL-24 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022047s024ltr.pdf
07/08/2011 SUPPL-23 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s023s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022047s023,s027ltr.pdf
12/02/2009 SUPPL-22 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022047s011s016s017s019s022ltr.pdf
12/02/2009 SUPPL-19 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022047s011s016s017s019s022ltr.pdf
08/14/2008 SUPPL-18 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s018ltr.pdf
12/02/2009 SUPPL-17 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022047s011s016s017s019s022ltr.pdf
12/02/2009 SUPPL-16 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022047s011s016s017s019s022ltr.pdf
08/11/2008 SUPPL-13 Labeling-Container/Carton Labels, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s013ltr.pdf
12/02/2009 SUPPL-11 Efficacy-New Indication Label (PDF)
Letter (PDF)
Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022047s011s016s017s019s022ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022047Orig1s011.pdf
05/21/2008 SUPPL-9 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s009ltr.pdf
10/08/2008 SUPPL-8 Efficacy-New Indication Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s006, s007, s008ltr.pdf
10/08/2008 SUPPL-7 Efficacy-New Indication Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s006, s007, s008ltr.pdf
10/08/2008 SUPPL-6 Efficacy-New Indication Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s006, s007, s008ltr.pdf
03/13/2008 SUPPL-2 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022047s002ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/23/2017 SUPPL-39 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022047s039lbl.pdf
02/23/2017 SUPPL-39 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022047s039lbl.pdf
06/17/2016 SUPPL-38 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022047s038lbl.pdf
01/26/2015 SUPPL-36 Manufacturing (CMC) Label (PDF) This supplement type does not usually require new labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022047s036lbl.pdf
10/29/2013 SUPPL-34 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s034lbl.pdf
04/30/2013 SUPPL-31 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf
04/30/2013 SUPPL-30 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf
04/30/2013 SUPPL-29 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf
04/30/2013 SUPPL-26 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022047s026s029s030s031lbl.pdf
07/08/2011 SUPPL-27 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s023s027lbl.pdf
07/08/2011 SUPPL-23 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s023s027lbl.pdf
05/17/2011 SUPPL-24 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022047s024lbl.pdf
12/01/2010 SUPPL-25 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022047s025lbl.pdf
12/02/2009 SUPPL-22 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf
12/02/2009 SUPPL-19 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf
12/02/2009 SUPPL-17 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf
12/02/2009 SUPPL-16 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf
12/02/2009 SUPPL-11 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf
10/08/2008 SUPPL-8 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf
10/08/2008 SUPPL-7 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf
10/08/2008 SUPPL-6 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf
08/11/2008 SUPPL-13 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s013lbl.pdf
08/11/2008 SUPPL-13 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s013lbl.pdf
03/13/2008 SUPPL-2 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s002lbl.pdf

SEROQUEL XR

TABLET, EXTENDED RELEASE;ORAL; EQ 50MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206252 ACCORD HLTHCARE
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 207655 AUROBINDO PHARMA LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202939 INTELLIPHARMACEUTICS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204203 LUPIN LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 208947 NOVAST LABS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090482 PAR PHARM
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206260 PHARMADAX INC
SEROQUEL XR QUETIAPINE FUMARATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 022047 ASTRAZENECA

TABLET, EXTENDED RELEASE;ORAL; EQ 200MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090681 ACCORD HLTHCARE
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090757 ANCHEN PHARMS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 207655 AUROBINDO PHARMA LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202939 INTELLIPHARMACEUTICS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204203 LUPIN LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204253 MACLEODS PHARMS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 208947 NOVAST LABS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090482 PAR PHARM
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206260 PHARMADAX INC
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 209635 SCIEGEN PHARMS INC
SEROQUEL XR QUETIAPINE FUMARATE EQ 200MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 022047 ASTRAZENECA

TABLET, EXTENDED RELEASE;ORAL; EQ 300MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090681 ACCORD HLTHCARE
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090757 ANCHEN PHARMS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 207655 AUROBINDO PHARMA LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202939 INTELLIPHARMACEUTICS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204203 LUPIN LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204253 MACLEODS PHARMS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 208947 NOVAST LABS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090482 PAR PHARM
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206260 PHARMADAX INC
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 209635 SCIEGEN PHARMS INC
SEROQUEL XR QUETIAPINE FUMARATE EQ 300MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 022047 ASTRAZENECA

TABLET, EXTENDED RELEASE;ORAL; EQ 400MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090681 ACCORD HLTHCARE
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090757 ANCHEN PHARMS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 207655 AUROBINDO PHARMA LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202939 INTELLIPHARMACEUTICS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204203 LUPIN LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204253 MACLEODS PHARMS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 208947 NOVAST LABS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090482 PAR PHARM
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206260 PHARMADAX INC
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 209635 SCIEGEN PHARMS INC
SEROQUEL XR QUETIAPINE FUMARATE EQ 400MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 022047 ASTRAZENECA

TABLET, EXTENDED RELEASE;ORAL; EQ 150MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090681 ACCORD HLTHCARE
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090757 ANCHEN PHARMS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 207655 AUROBINDO PHARMA LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202939 INTELLIPHARMACEUTICS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204203 LUPIN LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204253 MACLEODS PHARMS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 208947 NOVAST LABS LTD
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090482 PAR PHARM
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 206260 PHARMADAX INC
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 209635 SCIEGEN PHARMS INC
SEROQUEL XR QUETIAPINE FUMARATE EQ 150MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 022047 ASTRAZENECA

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English